Rendered at 10:14:43 GMT+0000 (Coordinated Universal Time) with Cloudflare Workers.
tjpnz 6 hours ago [-]
>Patients receiving amivantamab lived for a median of 12.5 months overall after starting treatment, despite having a form of cancer with very poor outcomes, once standard treatments stop working.
It's not a cure or the trial has been running <1 year?
It's not a cure or the trial has been running <1 year?